SCHEMBL461165

SCHEMBL461165

Cc1cc(C=C[N+](=O)[O-])c(F)cc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
PSMD14 O00487 1/20 0.52
KMT2A Q03164 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
FBP1 P09467 9/20 0.43
VCP P55072 3/20 0.42
ALDH1A1 P00352 4/20 0.40
MAPT P10636 4/20 0.40
MITF O75030 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 1/20 0.40
NTSR1 P30989 1/20 0.40
HSP90AA1 P07900 2/20 0.38
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
RXRA P19793 1/20 0.38
PRMT1 Q99873 1/20 0.37
NPSR1 Q6W5P4 1/20 0.35
ABL1 P00519 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL461799 1.00 MEN1 (0.52) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL18590415 0.95 MEN1 (0.54) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL145009 0.87 VCP (0.49) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL121200 0.87 VCP (0.49) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL16831526 0.81 VCP (0.50) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL16831527 0.81 VCP (0.50) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL19995519 0.79 VCP (0.58) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL19995518 0.79 VCP (0.58) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL458238 0.77 FBP1 (0.53) MEN1PSMD14KMT2AL3MBTL1FBP1
SCHEMBL458434 0.77 FBP1 (0.53) MEN1PSMD14KMT2AL3MBTL1FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed